White Pine Capital LLC Harvard Bioscience Inc Transaction History

White Pine Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$2.12 - $3.14 $26,924 - $39,878	-12,700 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.42 - $3.29 $3,976 - $9,212	-2,800 Reduced 18.06%	12,700 $28,000
Q4 2018 Feb 13, 2019	SELL	$3.03 - $5.0 $7,877 - $13,000	-2,600 Reduced 14.36%	15,500 $49,000
Q2 2018 Aug 14, 2018	SELL	$4.2 - $5.95 $42,420 - $60,095	-10,100 Reduced 35.82%	18,100 $97,000
Q3 2017 Nov 13, 2017	BUY	$2.7 - $3.75 $76,140 - $105,750	28,200	28,200 $106,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

Stay updated on White Pine Capital LLC with notifications on news.